# TOFACITINIB CITRATE
> **ANDA218668** · Abbreviated New Drug Application (Generic) · Sponsor: DEXCEL · Approved 2024-12-16
## Drug
- **FDA Application Number:** ANDA218668
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOFACITINIB CITRATE
- **Generic name:** Tofacitinib Citrate
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** DEXCEL
- **First approval:** 2024-12-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218668)
---
*AI Analytics · CC0 1.0*